Healthcare provider profile · identity verified

Scott R Perman, MD

Internal Medicine · NORWOOD, MA · NPI 1669478368

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	953	262
Amlodipine Besylate	Amlodipine Besylate	529	133
Lisinopril	Lisinopril	525	146
Simvastatin	Simvastatin	470	125
Omeprazole	Omeprazole	324	94
Levothyroxine Sodium	Levothyroxine Sodium	265	70
Metformin Hcl	Metformin Hcl	264	72
Losartan Potassium	Losartan Potassium	239	67
Tamsulosin Hcl	Tamsulosin Hcl	237	70
Rosuvastatin Calcium	Rosuvastatin Calcium	229	69
Hydrochlorothiazide	Hydrochlorothiazide	205	59
Metoprolol Succinate	Metoprolol Succinate	196	56
Metformin Hcl Er	Metformin Hcl	188	57
Atenolol	Atenolol	185	52
Sertraline Hcl	Sertraline Hcl	165	42
Pravastatin Sodium	Pravastatin Sodium	159	43
Allopurinol	Allopurinol	148	44
Gabapentin	Gabapentin	134	31
Warfarin Sodium	Warfarin Sodium	126	11
Trazodone Hcl	Trazodone Hcl	118	33
Eliquis	Apixaban	114	26
Pantoprazole Sodium	Pantoprazole Sodium	110	35
Lorazepam	Lorazepam	105	32
Citalopram Hbr	Citalopram Hydrobromide	100	30
Ozempic	Semaglutide	100	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	24
Clonazepam	Clonazepam	86	15
Furosemide	Furosemide	85	23
Famotidine	Famotidine	81	21
Azelastine Hcl	Azelastine Hcl	75	38
Finasteride	Finasteride	72	21
Jardiance	Empagliflozin	71	19
Trulicity	Dulaglutide	69	14
Prednisone	Prednisone	68	38
Clopidogrel	Clopidogrel Bisulfate	58	15
Tramadol Hcl	Tramadol Hcl	56	14
Zolpidem Tartrate	Zolpidem Tartrate	54	17
Mirtazapine	Mirtazapine	50	11
Xarelto	Rivaroxaban	49	12
Alprazolam	Alprazolam	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	19
Albuterol Sulfate Hfa	Albuterol Sulfate	46	22
Glipizide	Glipizide	46	12
Carvedilol	Carvedilol	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Meloxicam	Meloxicam	41	11
Buspirone Hcl	Buspirone Hcl	40	13
Fenofibrate	Fenofibrate,micronized	40	12
Metoprolol Tartrate	Metoprolol Tartrate	39	14
Valsartan	Valsartan	39	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Alendronate Sodium	Alendronate Sodium	36	13
Mounjaro	Tirzepatide	34	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	33	20
Baclofen	Baclofen	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Sildenafil Citrate	Sildenafil Citrate	31	suppressed
Celecoxib	Celecoxib	30	15
Ketoconazole	Ketoconazole	30	16
Levetiracetam	Levetiracetam	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	17
Hydrocortisone	Hydrocortisone	21	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	11
Telmisartan	Telmisartan	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Etodolac	Etodolac	18	13
Nystatin	Nystatin	18	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Digoxin	Digoxin	13	suppressed
Gralise	Gabapentin	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Epinephrine	Epinephrine	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Riluzole	Riluzole	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Diazepam	Diazepam	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error